Table 6

Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of risk criteria count (cumulative) and independent risk criteria in total patient cohort (n=20 109)

Sensitivity(95%  CI)Specificity(95% CI)PPV(95% CI)NPV(95% CI)
Risk criteria count
 0
 13.5(3.2 to to 3.9)100.0(99.9 to 100.0)99.0(97.3 to 99.7)47.2(46.5 to 47.9)
 28.4(7.6 to 9.4)99.6(99.5 to 99.7)84.3(80.3 to 87.8)82.2(81.7 to 82.8)
 317.1(15.1 to 19.3)99.1(99.0 to 99.3)58.0(52.8 to 63.0)94.6(94.2 to 94.9)
 426.3(22.0 to 30.9)98.6(98.4 to 98.7)27.2(22.8 to 31.9)98.5(98.3 to 98.7)
 536.6(26.2 to 48.0)98.2(98.0 to 98.4)7.8(5.3 to 11.0)99.7(99.7 to 99.8)
 657.1(18.4 to 90.1)98.1(97.9 to 98.3)1.0(0.3 to 2.7)100.0(100.0 to 100.0)
 7
Risk criteria
 1. Evidence of skull fracture10.6(9.3 to 12.0)99.1(98.9 to 99.2)56.4(51.3 to 61.4)90.8(90.4 to 91.2)
 2. Scalp haematoma4.1(3.6 to 4.7)99.0(98.8 to 99.2)62.4(57.3 to 67.3)71.8(71.1 to 72.4)
 3. Neurological deficits6.5(4.7 to 8.8)98.2(98.1 to 98.4)10.7(7.8 to 14.2)97.0(96.8 to 97.3)
 4. Altered levels of alertness12.4(10.9 to 13.9)99.2(99.0 to 99.3)61.4(56.3 to 66.3)91.6(91.2 to 92.0)
 5. Abnormal behaviour6.1(5.3 to 6.9)99.0(98.8 to 99.1)56.9(51.8 to 61.9)82.9(82.3 to 83.4)
 6. Persistent vomiting4.8(3.9 to 5.8)98.4(98.2 to 98.6)26.4(22.0 to 31.1)89.8(89.3 to 90.2)
 7. Coagulopathy3.8(2.0 to 6.5)98.1(97.9 to 98.3)3.1(1.6 to 5.4)98.5(98.3 to 98.6)